BackAmylyx Pharmaceuticals Overview

Amylyx Pharmaceuticals Other Current Assets

Latest other current assets for AMLX: $5.3M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$5.26M
55.37% YoYΔ $-6.52M vs prior year quarter

Peer average

Loading

Amylyx Pharmaceuticals Other Current Assets History

Loading

Amylyx Pharmaceuticals vs. peers: Other Current Assets Comparison

Loading

Amylyx Pharmaceuticals Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Amylyx Pharmaceuticals (AMLX) FAQ

As of the most recent data (March 2026), AMLX shows a other current assets of $5.3M. That compares with $12M in the prior-year period — down 55.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AMLX's other current assets is now $5.3M (was $12M) — a 55.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Amylyx Pharmaceuticals is outperforming or lagging.

Tracking AMLX's other current assets over time shows whether Amylyx Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $5.3M That compares with $12M in the prior-year period — down 55.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Amylyx Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $5.3M) with ownership activity and broader fundamentals.